Ignite Creation Date:
2024-07-17 @ 10:47 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06464185
Status:
RECRUITING
Last Update Posted:
2024-06-18
First Post:
2024-05-21
Brief Title:
A Prospective Clinical Study of CD3-CD20 Bisspecific Antibody Based Therapy Combined With CD19-CAR T Cells in the Treatment of Relapsed Refractory B-cell Non-Hodgkin Lymphoma
Sponsor:
Organization:
Institute of Hematology Blood Diseases Hospital China